FNY Managed Accounts’s Array Biopharma ARRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$2K Buy
+174
New +$2.79K ﹤0.01% 469
2017
Q2
– Sell
-750
Closed -$6K – 758
2017
Q1
$6K Buy
+750
New +$7.98K 0.02% 607

Other funds holding ARRY

FNY Managed Accounts's ARRY Position: Q1 2018 in Review

FNY Managed Accounts opened a new position in Array Biopharma (ARRY) in Q1 2018: 174 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #469 among its holdings. This is a return to the name: FNY Managed Accounts previously reported a position in ARRY as recently as Q1 2017.

FNY Managed Accounts first reported a position in ARRY in Q1 2017 and has held it in 2 quarters since. The position peaked at $6K in Q1 2017. 235 funds tracked by Wall St. Rank hold ARRY as of Q1 2018.

  • FNY Managed Accounts held 174 shares of Array Biopharma worth $2K as of Q1 2018.
  • Array Biopharma was a new FNY Managed Accounts position in Q1 2018.
  • Array Biopharma made up ﹤0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #469 holding.
  • FNY Managed Accounts first reported a position in Array Biopharma in Q1 2017 and has held it in 2 quarters since.
  • FNY Managed Accounts's Array Biopharma position peaked at $6K in Q1 2017.
  • 235 funds tracked by Wall St. Rank held Array Biopharma as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.